µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© SJ^
.#^)
Pon 2!
$
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© pvQw+jX
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© k/=J<?h0
1.Co-stimulators (or co-stimulating molecules) BhLYLlXPY
2.NK-kB ,h5\v WZ
3.Immunoglobulin superfamily mMjY I1F
4.antigen-presenting cell (APC) Yvs)H'n=
5.death domain f}0(qN/G
6.CCR and CXCR z 3fS+x:E{
7.Lectin (or mitogen) b/5?)!I
8.Clusters of differentiation, CD) s[NkPh9&
9.B7 family >y"W(
10.Cytotoxic T lymphocyte, CTL) $Lv,e\]
11.IL-15 and IL-15 receptor (IL-15R) d5fnJ*a>l
12.MHC restriction !fZ\GOx
13.Affinity-chromatography /T]2ZX>
14.Cyctosprin A, CsA G)]'>m<y
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) wUW^
O
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 7/a[;`i*!
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 *%7 [{Loz
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ *9y)B|P^
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ iagl^(s
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© >0Y >T6!
ÃâÒßѧרҵ£º I'HPy.PV
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ /17Qhex
Ïû»¯ÄÚ¿Æ£º m~'!
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ExeD3Zj
ѪҺ²¡Ñ§×¨Òµ£º ztTj2M"
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿